ferric pyrophosphate has been researched along with pyrophosphate in 81 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.23) | 18.7374 |
| 1990's | 5 (6.17) | 18.2507 |
| 2000's | 25 (30.86) | 29.6817 |
| 2010's | 39 (48.15) | 24.3611 |
| 2020's | 11 (13.58) | 2.80 |
| Authors | Studies |
|---|---|
| Cook, JD; Dassenko, SA; Hurrell, RF; Reddy, MB | 1 |
| Nilsen, T | 1 |
| Barker, J; Farrell, ID; Hutchison, JG | 1 |
| Kambayashi, J; Kawasaki, T; Mori, T; Sakon, M; Shiba, E; Tsuji, Y | 1 |
| Tampo, Y; Tsukamoto, M; Yonaha, M | 1 |
| Amin, NB; Anandan, JV; Besarab, A; Divine, GW; Gupta, A; Vogel, SE; Yee, J | 1 |
| Kawachi, A; Miyashita, M; Motoya, T; Yamada, K | 1 |
| Barclay, D; Davidsson, L; Hurrell, RF; Kastenmayer, P; Szajewska, H | 1 |
| Fukukawa, T; Kitano, K; Masuda, T; Ohtsuji, Y; Yamaguchi, H | 1 |
| Davidsson, L; Fidler, MC; Hurrell, RF; Juneja, LR; Sakaguchi, N; Walczyk, T; Zeder, C | 1 |
| Juneja, LR; Nakata, K; Nanbu, H; Rao, TP; Sakaguchi, N | 1 |
| Chaouki, N; Hurrell, RF; Rohner, F; Saïssi, M; Torresani, T; Wegmueller, R; Zeder, C; Zimmermann, MB | 1 |
| Arnold, M; Hurrell, RF; Langhans, W; Moretti, D; Wegmüller, R; Zimmermann, MB | 1 |
| Davidsson, L; Fidler, MC; Hurrell, RF; Marti, I; Walczyk, T; Zeder, C | 1 |
| Hurrell, RF; Moretti, D; Walczyk, T; Wegmüller, R; Zeder, C; Zimmermann, MB | 1 |
| Hurrell, RF; Kurpad, A; Moretti, D; Muthayya, S; Zimmermann, MB | 1 |
| Adou, P; Camara, F; Hurrell, RF; Wegmüller, R; Zimmermann, MB | 1 |
| Asante, KP; Christofides, A; Owusu-Agyei, S; Schauer, C; Sharieff, W; Zlotkin, S | 1 |
| Hurrell, RF; Kurpad, AV; Lee, TC; Moretti, D; Muthayya, S; Thankachan, P; Zimmermann, MB | 1 |
| Izquierdo-Pulido, M; Navas-Carretero, S; Pérez-Granados, AM; Sarriá, B; Schoppen, S; Vaquero, MP | 1 |
| Cianciotto, NP; Huston, WM; Jennings, MP; McEwan, AG; Naylor, J | 1 |
| Elliott, T; García-Guerra, A; Greiner, T; Hotz, C; Jankowski, S; Onofre, G; Porcayo, M | 1 |
| Navas-Carretero, S; Pérez-Granados, AM; Sarriá, B; Vaquero, MP | 1 |
| Angeles-Agdeppa, I; Barba, CV; Capanzana, MV; Florentino, RF; Takanashi, K | 1 |
| Arnoldi, S; Boccio, J; Kaliski, MA; Messeri, E; Salgueiro, MJ; Torti, H; Weill, R; Zubillaga, M | 1 |
| Haro-Vicente, JF; Martínez-Graciá, C; Pérez-Conesa, D; Rincón, F; Ros, G; Vidal, ML | 1 |
| Andersson, M; Goud, RB; Hurrell, RF; Kurpad, AV; Muthayya, S; Thankachan, P; Zimmermann, MB | 1 |
| Murthy, SN; Vaka, SR | 1 |
| Collings, R; Fairweather-Tait, SJ; Hoogewerff, J; Roe, MA | 1 |
| Davidsson, L; Hurrell, R; Jamil, KA; Sarker, SA; Sultana, S | 1 |
| Glahn, RP; Miller, DD; Nelson, D; Zhu, L | 1 |
| Murthy, SN; Shivakumar, HN; Vaka, SR | 2 |
| Dung, NT; Hien, VT; Khan, NC; Kise, M; Lam, NT; Nakamori, M; Okuhara, Y; Shigematsu, N; Shiomi, T; Uotsu, N; Yamamoto, S | 1 |
| Nakamura, M; Natsui, R; Nishimura, S; Yamada, A | 1 |
| Andersson, M; Duchateau, GS; Foman, JT; Frenken, LG; Hurrell, RF; Jäkel, M; Theis, W; Zimmermann, MB | 1 |
| Biebinger, R; Egli, I; Hurrell, RF; Zeder, C; Zimmermann, MB | 1 |
| Blanco-Rojo, R; Delgado, MA; González-Vizcayno, C; Pérez-Granados, AM; Toxqui, L; Vaquero, MP | 1 |
| Brahmam, GN; Kumar, RH; Nair, KM; Radhika, MS; Rao, MV; Ravinder, P; Reddy, CG | 1 |
| Chen, Y; Huang, Z; Jiang, J; Lin, Y; Pan, Y; Piao, J; Sun, J; Wang, L; Wang, Z; Xu, D; Yang, X; Zong, M | 1 |
| Grathwohl, D; Hurrell, RF; Kastenmayer, P; Storcksdieck Genannt Bonsmann, S; Walczyk, T; Zeder, C | 1 |
| Jo, S; Modepalli, N; Murthy, SN; Repka, MA | 1 |
| Bordalo, LA; Costa, NM; Della Lucia, CM; Martino, HS; Pinheiro-Sant'Ana, HM; Rodrigues, FC; Silveira, CM; Vaz Tostes, Md | 1 |
| Philipse, AP; Rossi, L; Velikov, KP | 1 |
| Alvares, EP; Colli, C; De Carli, E; Gaievski, EH; Lobo, AR | 1 |
| Biville, F; Brézillon, C; Giorgini, D; Taha, MK | 1 |
| Kanni, KL; Modepalli, N; Murthy, SN; Shivakumar, HN | 1 |
| Cournoyer, SH; Fanti, P; Fishbane, SN; Gupta, A; Guss, CD; Jindal, KK; Lin, VH; Pratt, RD; Singh, AK | 1 |
| Adiossan, LG; Brittenham, GM; Diakité, VG; Glinz, D; Hurrell, RF; N'Goran, EK; Ouattara, M; Righetti, AA; Seifert, B; Utzinger, J; Wegmüller, R; Zimmermann, MB | 1 |
| Banga, A; Donnelly, RF; McCrudden, MT; Modepalli, N; Murthy, SN; Shivakumar, HN | 1 |
| Adelmann, H; Cercamondi, CI; Hackl, L; Moretti, D; Wild, D; Zeder, C; Zimmermann, MB | 1 |
| Blanco, E; Smoukov, SK; Tian, T; Velev, OD; Velikov, KP | 1 |
| Fishbane, S; Hazzan, AD; Shah, HH | 1 |
| Cercamondi, CI; Duchateau, GS; Harika, RK; Koppenol, WP; Moretti, D; Murray, P; van den Berg, R; Zeder, C; Zimmermann, MB | 1 |
| Gupta, A; Ikizler, TA; Pratt, RD; Swinkels, DW | 1 |
| Al-Makki, A; Albright, T; Kalakeche, R; Shepler, B | 1 |
| Gupta, A; Hawkins, JV; Shetty, A | 1 |
| Fishbane, S; Shah, HH | 1 |
| Bose, B; Kurpad, AV; Mandal, AK; Mitra, G; Srinivasu, BY | 1 |
| Beconcini, D; Brilli, E; Carpi, S; Fabiano, A; Fogli, S; Tarantino, G; Zambito, Y | 1 |
| Honnavar, S; Maurya, A; Murthy, SN; Nanjappa, SH; Salwa, M | 1 |
| Costabile, L; D'Anna, R; Filati, P; Laganà, AS; Noventa, M; Vitagliano, A | 1 |
| Grimberg, S; Pratt, RD; Warady, BA; Zaritsky, JJ | 1 |
| Brilli, E; Citi, V; Fabiano, A; Mattii, L; Moscato, S; Tarantino, G; Testai, L; Zambito, Y | 1 |
| Arosio, P; Asperti, M; Brilli, E; Castagna, A; Corbella, M; Girelli, D; Gottardo, R; Gryzik, M; Poli, M; Tarantino, G | 1 |
| Edwards, TE; Gupta, A; Handelman, GJ; Pratt, R | 1 |
| Gupta, A; Mishra, B; Pratt, R | 1 |
| Castorina, S; Currenti, W; Longhitano, L; Mellini, G; Nicolosi, D; Palumbo, G; Pappalardo, A; Ponzio, R; Tibullo, D | 1 |
| Blonk, C; Duchateau, GS; Eilander, A; Funke, OM; Moretti, D; Murray, P; Owojuyigbe, TO; Zimmermann, MB | 1 |
| Banfi, G; Briguglio, M; Crespi, T; De Vecchi, E; Hrelia, S; Lombardi, G; Malaguti, M; Perazzo, P; Pino, F; Porrini, M; Riso, P; Romagnoli, S | 1 |
| Bries, AE; Hurrell, RF; Reddy, MB | 1 |
| Campanha da Rocha Ribeiro, T; de Alvarenga Antunes, CV; de Alvarenga Antunes, P; de Alvarenga Nascimento, CR; de Andrade Chebli, L; Malaguti, C; Maria Fonseca Chebli, J; Martins Gonçalves Fava, L | 1 |
| Herter-Aeberli, I; Jeroense, FMD; Zeder, C; Zimmermann, MB | 1 |
| Bodis, M; Dave, A; Dubascoux, S; Glahn, RP; Husny, J; Nicolas, M; Rytz, A; Sabatier, M; Singh, H | 1 |
| Caruso, S; Commodari, E; Fiore, M; La Rosa, VL; Mazza, G; Paratore, M; Rapisarda, AMC; Vitale, SG | 1 |
| Marbury, T; Pratt, RD; van der Horst, E; van Heuveln, F | 1 |
| Egli, I; Foman, JT; Hurrell, RF; Kastenmayer, P; Li, Q; Mallillin, AC; Rytz, A; Sabatier, M; Sagum, RS; Trinidad, TP; Zeder, C | 1 |
| Fang, Y; Gan, L; Hui, AM; Li, K; Pratt, R; Tan, Y; Wei, G; Xie, P; Yuan, X; Zhang, L; Zheng, Q; Zhou, Y; Zuo, L | 1 |
| Fishbane, S; Ganz, T; Pratt, RD | 1 |
| Bijlsma, J; de Bruijn, WJC; Kegel, WK; Moslehi, N; Velikov, KP; Vincken, JP | 1 |
3 review(s) available for ferric pyrophosphate and pyrophosphate
| Article | Year |
|---|---|
Ferric Pyrophosphate Citrate: A Novel Iron Replacement Agent in Patients Undergoing Hemodialysis.
Topics: Anemia, Iron-Deficiency; Dialysis Solutions; Diphosphates; Ferric Compounds; Hematinics; Humans; Iron; Kidney Failure, Chronic; Renal Dialysis | 2016 |
A Review of Ferric Pyrophosphate Citrate (Triferic) Use in Hemodialysis Patients.
Topics: Administration, Intravenous; Citrates; Dietary Supplements; Diphosphates; Ferritins; Hematinics; Hemoglobins; Humans; Iron; Renal Dialysis; Renal Insufficiency, Chronic | 2016 |
Ferric pyrophosphate citrate as an iron replacement agent for patients receiving hemodialysis.
Topics: Anemia; Clinical Trials as Topic; Diphosphates; Hematinics; Humans; Iron; Kidney Failure, Chronic; Renal Dialysis | 2017 |
37 trial(s) available for ferric pyrophosphate and pyrophosphate
| Article | Year |
|---|---|
Ferrous fumarate fortification of a chocolate drink powder.
Topics: Adolescent; Ascorbic Acid; Beverages; Biological Availability; Cacao; Child; Diphosphates; Ferrous Compounds; Food Handling; Food, Fortified; Humans; Intestinal Absorption; Iron; Iron Radioisotopes | 1991 |
Effect of recombinant human erythropoietin on anaemia after gastrectomy: a pilot study.
Topics: Adult; Aged; Anemia; Blood Cell Count; Diphosphates; Erythropoietin; Female; Gastrectomy; Hematocrit; Hemoglobins; Humans; Iron; Male; Middle Aged; Pilot Projects; Postoperative Care; Postoperative Complications; Preoperative Care; Recombinant Proteins; Stomach Neoplasms; Time Factors | 1995 |
Dialysate iron therapy: infusion of soluble ferric pyrophosphate via the dialysate during hemodialysis.
Topics: Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Dialysis Solutions; Diphosphates; Drug Administration Routes; Erythropoietin; Female; Ferritins; Hemoglobins; Humans; Iron; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Solubility; Transferrin | 1999 |
Iron bioavailability in infants from an infant cereal fortified with ferric pyrophosphate or ferrous fumarate.
Topics: Biological Availability; Diphosphates; Edible Grain; Erythrocytes; Female; Ferrous Compounds; Food, Fortified; Glycine max; Humans; Infant; Infant Food; Iron; Iron Isotopes; Male; Triticum | 2000 |
Dual fortification of salt with iodine and micronized ferric pyrophosphate: a randomized, double-blind, controlled trial.
Topics: Adolescent; Adolescent Nutritional Physiological Phenomena; Anemia, Iron-Deficiency; Biological Availability; Child; Child Nutritional Physiological Phenomena; Diphosphates; Double-Blind Method; Female; Food Handling; Food, Fortified; Goiter; Humans; Intestinal Absorption; Iodine; Iron; Iron, Dietary; Male; Morocco; Prevalence; Rural Health; Sodium Chloride, Dietary; Thyroid Gland; Time Factors; Treatment Outcome | 2004 |
Effect of ascorbic acid and particle size on iron absorption from ferric pyrophosphate in adult women.
Topics: Adult; Ascorbic Acid; Biological Availability; Diphosphates; Erythrocytes; Female; Ferrous Compounds; Humans; Iron; Iron Isotopes; Iron, Dietary; Particle Size; Time Factors | 2004 |
Iron status and food matrix strongly affect the relative bioavailability of ferric pyrophosphate in humans.
Topics: Absorption; Adult; Antioxidants; Ascorbic Acid; Biological Availability; Cross-Over Studies; Diphosphates; Female; Ferritins; Ferrous Compounds; Food; Food Handling; Food, Fortified; Humans; Intestinal Absorption; Iron; Iron Isotopes; Nutritional Status; Oryza; Triticum | 2006 |
Iron fortification reduces blood lead levels in children in Bangalore, India.
Topics: Adolescent; Child; Child, Preschool; Diphosphates; Double-Blind Method; Food, Fortified; Humans; India; Iron; Iron Deficiencies; Lead; Lead Poisoning; Urban Population | 2006 |
Salt dual-fortified with iodine and micronized ground ferric pyrophosphate affects iron status but not hemoglobin in children in Cote d'Ivoire.
Topics: Adolescent; Anemia, Iron-Deficiency; Biological Availability; Child; Child, Preschool; Cote d'Ivoire; Diphosphates; Double-Blind Method; Female; Hemoglobins; Humans; Intestinal Absorption; Iodine; Iron; Iron, Dietary; Malaria; Male; Prevalence; Rural Health; Sodium Chloride, Dietary | 2006 |
Multi-micronutrient Sprinkles including a low dose of iron provided as microencapsulated ferrous fumarate improves haematologic indices in anaemic children: a randomized clinical trial.
Topics: Administration, Oral; Anemia, Iron-Deficiency; Capsules; Dietary Supplements; Diphosphates; Dose-Response Relationship, Drug; Female; Ferrous Compounds; Food, Fortified; Ghana; Hemoglobins; Humans; Infant; Iron; Male; Micronutrients; Patient Compliance; Prospective Studies; Treatment Outcome | 2006 |
Extruded rice fortified with micronized ground ferric pyrophosphate reduces iron deficiency in Indian schoolchildren: a double-blind randomized controlled trial.
Topics: Adolescent; Anemia, Iron-Deficiency; Biological Availability; Child; Diphosphates; Double-Blind Method; Female; Food Services; Food, Fortified; Hemoglobins; Humans; India; Iron; Male; Oryza; School Health Services | 2006 |
Efficacy of iron-fortified Ultra Rice in improving the iron status of women in Mexico.
Topics: Adolescent; Adult; Anemia, Iron-Deficiency; Diphosphates; Female; Ferritins; Food, Fortified; Hemoglobins; Humans; Iron; Iron, Dietary; Mexico; Middle Aged; Nutritional Status; Oryza; Prevalence; Receptors, Transferrin; Treatment Outcome | 2008 |
Iron absorption from meat pate fortified with ferric pyrophosphate in iron-deficient women.
Topics: Adult; Anemia, Iron-Deficiency; Area Under Curve; Biological Availability; Cross-Over Studies; Diphosphates; Double-Blind Method; Female; Food, Fortified; Humans; Intestinal Absorption; Iron; Iron, Dietary; Liposomes; Meat Products; Postprandial Period; Young Adult | 2009 |
Efficacy of iron-fortified rice in reducing anemia among schoolchildren in the Philippines.
Topics: Anemia, Iron-Deficiency; C-Reactive Protein; Child; Child Nutritional Physiological Phenomena; Diphosphates; Double-Blind Method; Eating; Ferritins; Ferrous Compounds; Food, Fortified; Hemoglobins; Humans; Iron; Oryza; Philippines; Statistics, Nonparametric; Vitamin A | 2008 |
Dual fortification of salt with iodine and iron: a randomized, double-blind, controlled trial of micronized ferric pyrophosphate and encapsulated ferrous fumarate in southern India.
Topics: Adolescent; Anemia, Iron-Deficiency; Biological Availability; Child; Child Nutritional Physiological Phenomena; Child, Preschool; Diphosphates; Double-Blind Method; Female; Ferritins; Ferrous Compounds; Food, Fortified; Goiter; Hemoglobins; Humans; India; Iodine; Iron; Iron Deficiencies; Iron, Dietary; Male; Prevalence; Rural Health; Sodium Chloride, Dietary; Treatment Outcome | 2008 |
Regular consumption of a complementary food fortified with ascorbic acid and ferrous fumarate or ferric pyrophosphate is as useful as ferrous sulfate in maintaining hemoglobin concentrations >105 g/L in young Bangladeshi children.
Topics: Anemia, Iron-Deficiency; Ascorbic Acid; Bangladesh; C-Reactive Protein; Child, Preschool; Diphosphates; Female; Ferritins; Ferrous Compounds; Food, Fortified; Hemoglobins; Humans; Infant; Iron; Iron, Dietary; Male; Trace Elements | 2009 |
Difructose anhydride III enhances bioavailability of water-insoluble iron in anemic Vietnamese women.
Topics: Adjuvants, Pharmaceutic; Adult; Algorithms; Anemia, Iron-Deficiency; Biological Availability; Diphosphates; Disaccharides; Double-Blind Method; Female; Ferrous Compounds; Hemoglobins; Humans; Iron; Middle Aged; Nutritional Status; Receptors, Transferrin; Severity of Illness Index; Solubility; Time Factors; Transferrin; Vietnam; Young Adult | 2010 |
Random serial sampling to evaluate efficacy of iron fortification: a randomized controlled trial of margarine fortification with ferric pyrophosphate or sodium iron edetate.
Topics: Adolescent; Adult; Analysis of Variance; Anemia, Iron-Deficiency; Diphosphates; Double-Blind Method; Edetic Acid; Female; Ferric Compounds; Ferritins; Food, Fortified; Humans; Iron; Iron, Dietary; Margarine; Models, Biological; Nutrition Assessment; Sample Size; Young Adult | 2010 |
Iron deficiency up-regulates iron absorption from ferrous sulphate but not ferric pyrophosphate and consequently food fortification with ferrous sulphate has relatively greater efficacy in iron-deficient individuals.
Topics: Adolescent; Adult; Anemia, Iron-Deficiency; Biological Availability; C-Reactive Protein; Child; Diphosphates; Female; Ferritins; Ferrous Compounds; Food, Fortified; Hemoglobins; Humans; Intestinal Absorption; Intestines; Iodine; Iron; Iron Isotopes; Iron, Dietary; Male; Nutritional Status; Sodium Chloride, Dietary; Solubility; Young Adult | 2011 |
Efficacy of a microencapsulated iron pyrophosphate-fortified fruit juice: a randomised, double-blind, placebo-controlled study in Spanish iron-deficient women.
Topics: Adolescent; Adult; Anemia, Iron-Deficiency; Beverages; Blood Pressure; Body Weight; Diet; Dietary Supplements; Diphosphates; Double-Blind Method; Drug Compounding; Feeding Behavior; Female; Fruit; Humans; Iron; Motor Activity; Spain; Young Adult | 2011 |
Micronized ferric pyrophosphate supplied through extruded rice kernels improves body iron stores in children: a double-blind, randomized, placebo-controlled midday meal feeding trial in Indian schoolchildren.
Topics: Anemia, Iron-Deficiency; C-Reactive Protein; Child; Child, Preschool; Diphosphates; Double-Blind Method; Female; Ferritins; Food, Fortified; Hemoglobins; Humans; India; Iron; Male; Oryza; Placebos; Rural Population; Schools; Statistics, Nonparametric | 2011 |
[Effect of iron supplementation on iron deficiency anemia of childbearing age women in Shanghai].
Topics: Adult; Anemia, Iron-Deficiency; Diphosphates; Female; Ferrous Compounds; Humans; Iron; Middle Aged; Young Adult | 2012 |
Ferrous ammonium phosphate (FeNH₄PO₄) as a new food fortificant: iron bioavailability compared to ferrous sulfate and ferric pyrophosphate from an instant milk drink.
Topics: Adult; Beverages; Cross-Over Studies; Dairy Products; Diphosphates; Double-Blind Method; Erythrocytes; Female; Ferrous Compounds; Food, Fortified; Food, Preserved; Humans; Intestinal Absorption; Iron; Iron Isotopes; Iron, Dietary; Nutritive Value; Phosphates; Solubility; Young Adult | 2013 |
Ferric pyrophosphate citrate (Triferic™) administration via the dialysate maintains hemoglobin and iron balance in chronic hemodialysis patients.
Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Dialysis Solutions; Dietary Supplements; Diphosphates; Female; Ferric Compounds; Hematinics; Hemoglobins; Humans; Iron; Male; Middle Aged; Prospective Studies; Renal Dialysis; Single-Blind Method; Treatment Outcome | 2015 |
The effect of iron-fortified complementary food and intermittent preventive treatment of malaria on anaemia in 12- to 36-month-old children: a cluster-randomised controlled trial.
Topics: Amodiaquine; Anemia; Antimalarials; Child, Preschool; Cote d'Ivoire; Diphosphates; Drug Combinations; Edetic Acid; Ferric Compounds; Food, Fortified; Hemoglobins; Humans; Infant; Inflammation; Iron; Iron Deficiencies; Malaria; Male; Prevalence; Pyrimethamine; Sulfadoxine | 2015 |
Cofortification of ferric pyrophosphate and citric acid/trisodium citrate into extruded rice grains doubles iron bioavailability through in situ generation of soluble ferric pyrophosphate citrate complexes.
Topics: Adolescent; Adult; Biological Availability; Body Mass Index; Body Weight; C-Reactive Protein; Citrates; Citric Acid; Cooking; Cross-Over Studies; Diphosphates; Erythrocytes; Female; Food, Fortified; Humans; Iron; Iron, Dietary; Nutritional Status; Oryza; Single-Blind Method; Young Adult | 2016 |
Sodium pyrophosphate enhances iron bioavailability from bouillon cubes fortified with ferric pyrophosphate.
Topics: Adolescent; Adult; Biological Availability; Caco-2 Cells; Digestion; Diphosphates; Erythrocytes; Female; Ferritins; Ferrous Compounds; Food, Fortified; Humans; Intestinal Absorption; Iron; Solubility; Young Adult | 2016 |
Pharmacokinetics of Ferric Pyrophosphate Citrate, a Novel Iron Salt, Administered Intravenously to Healthy Volunteers.
Topics: Administration, Intravenous; Adolescent; Adult; Biomarkers; Citrates; Diphosphates; Dose-Response Relationship, Drug; Double-Blind Method; Female; Half-Life; Healthy Volunteers; Hematinics; Humans; Inflammation Mediators; Iron; Male; Middle Aged; Oxidative Stress; Renal Dialysis; Young Adult | 2017 |
Effects of micronised dispersible ferric pyrophosphate combined with alpha-lactalbumin in pregnant women affected by iron deficiency anemia: results from a prospective, double-blind, randomized controlled trial.
Topics: Adult; Anemia, Iron-Deficiency; Diphosphates; Double-Blind Method; Drug Compounding; Female; Ferrous Compounds; Gestational Age; Humans; Iron; Lactalbumin; Pregnancy; Prospective Studies; Young Adult | 2018 |
Pharmacokinetics of ferric pyrophosphate citrate administered via dialysate and intravenously to pediatric patients on chronic hemodialysis.
Topics: Administration, Intravenous; Adolescent; Anemia, Iron-Deficiency; Child; Child, Preschool; Dialysis Solutions; Diphosphates; Feasibility Studies; Female; Hematinics; Hemoglobins; Humans; Infant; Iron; Male; Renal Dialysis; Renal Insufficiency, Chronic; Treatment Outcome | 2018 |
Effects of micronised microencapsulated ferric pyrophosphate supplementation in patients with advanced cancer and iron deficiency: a single-centre cohort pilot study.
Topics: Administration, Intravenous; Administration, Oral; Aged; Anemia, Iron-Deficiency; Diphosphates; Female; Humans; Iron; Iron Deficiencies; Male; Middle Aged; Neoplasms; Pilot Projects; Prospective Studies | 2019 |
High Bioavailability from Ferric Pyrophosphate-Fortified Bouillon Cubes in Meals is Not Increased by Sodium Pyrophosphate: a Stable Iron Isotope Study in Young Nigerian Women.
Topics: Adult; Anemia; Anemia, Iron-Deficiency; Biological Availability; Cross-Over Studies; Diphosphates; Double-Blind Method; Erythrocytes; Female; Food, Fortified; Humans; Intestinal Absorption; Iron; Iron Isotopes; Meals; Nigeria; Young Adult | 2019 |
Oral Supplementation with Sucrosomial Ferric Pyrophosphate Plus L-Ascorbic Acid to Ameliorate the Martial Status: A Randomized Controlled Trial.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Arthroplasty, Replacement; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Ascorbic Acid; Dietary Supplements; Diphosphates; Female; Ferric Compounds; Hematinics; Hematology; Hemoglobins; Humans; Iron; Male; Middle Aged; Preoperative Care | 2020 |
Iron Absorption from Bouillon Fortified with Iron-Enriched Aspergillus oryzae Is Higher Than That Fortified with Ferric Pyrophosphate in Young Women.
Topics: Adolescent; Adult; Aspergillus oryzae; Cross-Over Studies; Diphosphates; Female; Food, Fortified; Humans; Iron; Young Adult | 2020 |
Treatment of iron deficiency anemia with liposomal iron in inflammatory bowel disease: efficacy and impact on quality of life.
Topics: Adolescent; Adult; Anemia, Iron-Deficiency; Diphosphates; Drug Carriers; Fatigue; Female; Hemoglobins; Humans; Inflammatory Bowel Diseases; Iron; Liposomes; Male; Middle Aged; Prospective Studies; Quality of Life; Transferrin; Young Adult | 2020 |
Pharmacokinetics and Safety of Intravenous Ferric Pyrophosphate Citrate: Equivalence to Administration via Dialysate.
Topics: Administration, Intravenous; Citric Acid; Cross-Over Studies; Dialysis Solutions; Diphosphates; Hematinics; Humans; Iron; Kidney Failure, Chronic; Renal Dialysis | 2022 |
Iron Bioavailability from Ferrous Ammonium Phosphate, Ferrous Sulfate, and Ferric Pyrophosphate in an Instant Milk Drink-A Stable Isotope Study in Children.
Topics: Animals; Biological Availability; Child; Child, Preschool; Cross-Over Studies; Diphosphates; Female; Ferrous Compounds; Food, Fortified; Humans; Intestinal Absorption; Iron; Iron Isotopes; Iron, Dietary; Isotopes; Milk; Phosphates | 2022 |
41 other study(ies) available for ferric pyrophosphate and pyrophosphate
| Article | Year |
|---|---|
Effects of calcium on hepatocyte iron uptake from transferrin, iron-pyrophosphate and iron-ascorbate.
Topics: Animals; Ascorbic Acid; Calcium; Cell Separation; Diphosphates; Endocytosis; Ferrous Compounds; Iron; Kinetics; Liver; Male; Rats; Rats, Inbred Strains; Temperature; Transferrin | 1991 |
Factors affecting growth of Legionella pneumophila in liquid media.
Topics: Culture Media; Cysteine; Diphosphates; Erythrocytes; Iron; Legionella; Sodium Chloride | 1986 |
The antioxidant action of 2-methyl-6-(p-methoxyphenyl)-3,7-dihydroimidazo[1,2-alpha]pyra z in-3-one (MCLA), a chemiluminescence probe to detect superoxide anions.
Topics: Amidines; Animals; Antioxidants; Benzene Derivatives; Diphosphates; Free Radical Scavengers; Imidazoles; Iron; Lipid Peroxidation; Liposomes; Luminescent Measurements; Male; Microsomes, Liver; Molecular Probes; Oxygen Consumption; Pyrazines; Rats; Rats, Sprague-Dawley; Superoxides; Thiobarbituric Acid Reactive Substances | 1998 |
Effects of ascorbic acid on interactions between ciprofloxacin and ferrous sulphate, sodium ferrous citrate or ferric pyrophosphate, in mice.
Topics: Absorption; Administration, Oral; Animals; Anti-Infective Agents; Ascorbic Acid; Ciprofloxacin; Citric Acid; Diphosphates; Drug Interactions; Ferrous Compounds; Iron; Iron Compounds; Male; Mice | 2000 |
Mutagenicity and DNA-damaging activity caused by decomposed products of potassium sorbate reacting with ascorbic acid in the presence of Fe salt.
Topics: Ascorbic Acid; Diphosphates; DNA Damage; Edetic Acid; Ferric Compounds; Ferrous Compounds; Food Preservatives; Iron; Mutagenicity Tests; Ribosomal Proteins; Salmonella typhimurium; Sorbic Acid | 2002 |
A micronised, dispersible ferric pyrophosphate with high relative bioavailability in man.
Topics: Absorption; Adult; Beverages; Biological Availability; Diphosphates; Edible Grain; Erythrocytes; Female; Ferrous Compounds; Food, Fortified; Humans; Iron; Iron Isotopes; Iron, Dietary; Yogurt | 2004 |
Iron absorption and bioavailability in rats of micronized dispersible ferric pyrophosphate.
Topics: Analysis of Variance; Animals; Area Under Curve; Biological Availability; Citric Acid; Diphosphates; Ferrous Compounds; Hemoglobins; Iron; Iron, Dietary; Male; Particle Size; Rats; Rats, Sprague-Dawley | 2004 |
Particle size reduction and encapsulation affect the bioavailability of ferric pyrophosphate in rats.
Topics: Animals; Biological Availability; Capsules; Diphosphates; Ferrous Compounds; Intestinal Absorption; Iron; Male; Rats; Rats, Sprague-Dawley | 2004 |
A comparative study of iron bioavailability from cocoa supplemented with ferric pyrophosphate or ferrous fumarate in rats.
Topics: Anemia, Iron-Deficiency; Animals; Biological Availability; Cacao; Diet; Diphosphates; Female; Ferrous Compounds; Food, Fortified; Hemoglobins; Iron; Iron, Dietary; Liposomes; Liver; Male; Random Allocation; Rats; Rats, Wistar; Spleen | 2007 |
Functional analysis of the multi-copper oxidase from Legionella pneumophila.
Topics: Aerobiosis; Animals; Base Sequence; Cell Membrane; Copper Sulfate; Diphosphates; Disk Diffusion Antimicrobial Tests; DNA, Bacterial; Ferrous Compounds; Genes, Bacterial; Hartmannella; Humans; Iron; Laccase; Legionella pneumophila; Legionnaires' Disease; Molecular Sequence Data; Mutagenesis, Insertional; Oxidoreductases; Sequence Analysis, DNA; U937 Cells | 2008 |
Stabilized-solubilized ferric pyrophosphate as a new iron source for food fortification. Bioavailability studies by means of the prophylactic-preventive method in rats.
Topics: Analysis of Variance; Animals; Biological Availability; Diet; Diphosphates; Female; Ferrous Compounds; Food, Fortified; Iron; Iron, Dietary; Random Allocation; Rats; Rats, Sprague-Dawley; Reference Standards; Solubility; Water; Yogurt | 2009 |
Does ascorbic acid supplementation affect iron bioavailability in rats fed micronized dispersible ferric pyrophosphate fortified fruit juice?
Topics: Anemia, Iron-Deficiency; Animals; Antioxidants; Ascorbic Acid; Beverages; Biological Availability; Dietary Supplements; Diphosphates; Food, Fortified; Hemoglobins; Intestinal Absorption; Iron; Iron, Dietary; Male; Particle Size; Random Allocation; Rats; Rats, Sprague-Dawley; Solubility | 2008 |
Irontophoresis: transdermal delivery of iron by iontophoresis.
Topics: Administration, Cutaneous; Animals; Diphosphates; Drug Delivery Systems; In Vitro Techniques; Iontophoresis; Iron; Rats; Rats, Hairless; Skin Absorption | 2009 |
Relative bioavailability of micronized, dispersible ferric pyrophosphate added to an apple juice drink.
Topics: Absorption; Adolescent; Adult; Aged; Beverages; Biological Availability; C-Reactive Protein; Diphosphates; Female; Ferritins; Ferrous Compounds; Food, Fortified; Fruit; Hemoglobins; Humans; Iron; Iron Deficiencies; Iron Isotopes; Malus; Middle Aged; Particle Size | 2009 |
Comparing soluble ferric pyrophosphate to common iron salts and chelates as sources of bioavailable iron in a Caco-2 cell culture model.
Topics: Biological Availability; Caco-2 Cells; Diphosphates; Humans; Iron; Iron Chelating Agents; Iron, Dietary; Models, Biological; Phytic Acid; Solubility; Tannins | 2009 |
Albumin microspheres for oral delivery of iron.
Topics: Administration, Oral; Animals; Area Under Curve; Cattle; Chemistry, Pharmaceutical; Diphosphates; Drug Carriers; Drug Delivery Systems; Iron; Male; Microspheres; Particle Size; Peyer's Patches; Rats; Rats, Sprague-Dawley; Serum Albumin, Bovine; Time Factors | 2010 |
Constant voltage 'Iron'tophoresis.
Topics: Administration, Cutaneous; Anemia, Iron-Deficiency; Animals; Diphosphates; Drug Delivery Systems; Electroporation; Epidermis; Humans; Iontophoresis; Iron; Skin Absorption; Sus scrofa | 2011 |
[Polish Gynecological Society Experts' position on the use of Pregnamedc zelazo in gynecology and obstetrics].
Topics: Diphosphates; Female; Gynecology; Humans; Inservice Training; Iron; Iron Chelating Agents; Iron, Dietary; Obstetrics; Poland; Practice Guidelines as Topic; Quality Assurance, Health Care; Societies, Medical; Women's Health | 2010 |
New lithium iron pyrophosphate as 3.5 V class cathode material for lithium ion battery.
Topics: Diphosphates; Electric Power Supplies; Electrochemistry; Electrodes; Iron; Lithium; Models, Molecular | 2010 |
Microporation and 'iron'tophoresis for treating iron deficiency anemia.
Topics: Administration, Cutaneous; Anemia, Iron-Deficiency; Animals; Diphosphates; Drug Delivery Systems; Erythrocytes; Iontophoresis; Iron; Male; Needles; Rats; Rats, Hairless | 2013 |
Iron bioavailability in Wistar rats fed with fortified rice by Ultra Rice technology with or without addition of yacon flour (Smallanthus sonchifolius).
Topics: Animal Feed; Animals; Asteraceae; Biological Availability; Body Weight; Diphosphates; Fatty Acids, Volatile; Feces; Food, Fortified; Iron; Iron, Dietary; Male; Oryza; Rats; Rats, Wistar | 2013 |
Colloidal iron(III) pyrophosphate particles.
Topics: Colloids; Diphosphates; Ferric Compounds; Iron | 2014 |
Fructo-oligosaccharides and iron bioavailability in anaemic rats: the effects on iron species distribution, ferroportin-1 expression, crypt bifurcation and crypt cell proliferation in the caecum.
Topics: Anemia, Iron-Deficiency; Animals; Brazil; Cation Transport Proteins; Cecum; Cell Proliferation; Diphosphates; Ferrous Compounds; Food, Fortified; Fructose; Gastrointestinal Contents; Hemoglobins; Intestinal Mucosa; Iron; Iron, Dietary; Male; Nutritive Value; Oligosaccharides; Plant Roots; Prebiotics; Rats, Wistar; Tracheophyta | 2014 |
Pyrophosphate-mediated iron acquisition from transferrin in Neisseria meningitidis does not require TonB activity.
Topics: Animals; Bacterial Proteins; Biological Transport; Deferoxamine; Diphosphates; Disease Models, Animal; Humans; Iron; Membrane Proteins; Meningitis, Meningococcal; Mice; Microbial Viability; Neisseria meningitidis; Transferrin | 2014 |
Transdermal iron replenishment therapy.
Topics: Administration, Cutaneous; Anemia, Iron-Deficiency; Animals; Diphosphates; Drug Delivery Systems; Humans; Iontophoresis; Iron; Iron-Dextran Complex; Rats; Skin Absorption; Technology, Pharmaceutical | 2015 |
Transdermal Delivery of Iron Using Soluble Microneedles: Dermal Kinetics and Safety.
Topics: Administration, Cutaneous; Animals; Cell Survival; Diphosphates; Drug Delivery Systems; Fibroblasts; Humans; Iron; Kinetics; Microinjections; Needles; Rats; Rats, Hairless; Reactive Oxygen Species; Safety; Skin; Skin Absorption | 2016 |
Dissolution behaviour of ferric pyrophosphate and its mixtures with soluble pyrophosphates: Potential strategy for increasing iron bioavailability.
Topics: Beverages; Biological Availability; Dietary Supplements; Diphosphates; Food, Fortified; Humans; Iron; Solubility | 2016 |
Peritoneal Dialysis Using Soluble Ferric Pyrophosphate as an Iron Supplement in Rabbits.
Topics: Anemia, Iron-Deficiency; Animals; Diphosphates; Disease Models, Animal; Injections, Intraperitoneal; Iron; Peritoneal Dialysis; Pilot Projects; Rabbits; Random Allocation; Reference Values; Risk Factors; Treatment Outcome | 2017 |
Adsorption Induced Changes of Human Hemoglobin on Ferric Pyrophosphate Nanoparticle Surface Probed by Isotope Exchange Mass Spectrometry: An Implication on Structure-Function Correlation.
Topics: Adsorption; Diphosphates; Hemoglobins; Humans; Iron; Isotopes; Mass Spectrometry; Metal Nanoparticles | 2017 |
Sucrosomial® iron absorption studied by in vitro and ex-vivo models.
Topics: Animals; Biological Transport; Body Fluids; Caco-2 Cells; Diphosphates; Dosage Forms; Drug Liberation; Humans; Intestinal Mucosa; Iron; Lecithins; Rats; Sucrose | 2018 |
Rapidly Dissolving Microneedle Patches for Transdermal Iron Replenishment Therapy.
Topics: Administration, Cutaneous; Anemia, Iron-Deficiency; Animals; Diphosphates; Drug Delivery Systems; Humans; Iron; Male; Needles; Rats; Rats, Sprague-Dawley; Skin Absorption; Solubility; Transdermal Patch | 2018 |
Ex Vivo and in Vivo Study of Sucrosomial
Topics: Animals; Diphosphates; Intestinal Absorption; Iron; Lecithins; Macrophages; Male; Microscopy, Confocal; Rats; Rats, Wistar | 2018 |
Sucrosomial
Topics: Anemia, Iron-Deficiency; Animals; Diphosphates; Disease Models, Animal; Female; Ferric Compounds; Ferrous Compounds; Hep G2 Cells; Hepcidins; Humans; Inflammation; Intestinal Absorption; Intestines; Iron; Iron Deficiencies; Mice, Inbred BALB C | 2018 |
Ferric pyrophosphate citrate: interactions with transferrin.
Topics: Binding Sites; Citric Acid; Crystallography, X-Ray; Diphosphates; Humans; Iron; Kinetics; Models, Molecular; Transferrin | 2018 |
Physicochemical characterization of ferric pyrophosphate citrate.
Topics: Chemistry, Physical; Citric Acid; Diphosphates; Iron; Molecular Structure | 2018 |
Acute Consumption of Prebiotic Galacto-Oligosaccharides Increases Iron Absorption from Ferrous Fumarate, but not from Ferrous Sulfate and Ferric Pyrophosphate: Stable Iron Isotope Studies in Iron-Depleted Young Women.
Topics: Anemia, Iron-Deficiency; Biological Transport; Cross-Over Studies; Diphosphates; Drug Administration Schedule; Female; Ferrous Compounds; Humans; Iron; Iron Isotopes; Prebiotics; Prospective Studies; Young Adult | 2020 |
Impact of Ascorbic Acid on the In Vitro Iron Bioavailability of a Casein-Based Iron Fortificant.
Topics: Ascorbic Acid; Biological Availability; Caco-2 Cells; Caseins; Cells, Cultured; Diphosphates; Ferrous Compounds; Food, Fortified; Humans; In Vitro Techniques; Iron | 2020 |
Liposomal ferric pyrophosphate and ascorbic acid supplementation in pregnant women with iron deficiency anaemia: haematochemical, obstetric, neonatal and psychological outcomes in a prospective observational study.
Topics: Anemia, Iron-Deficiency; Ascorbic Acid; Dietary Supplements; Diphosphates; Female; Humans; Infant, Newborn; Iron; Iron Deficiencies; Pregnancy; Pregnant Women; Quality of Life | 2022 |
Ethnicity evaluation of ferric pyrophosphate citrate among Asian and Non-Asian populations: a population pharmacokinetics analysis.
Topics: Citrates; Dialysis Solutions; Diphosphates; Ethnicity; Hematinics; Humans; Iron; Kidney Failure, Chronic; Reproducibility of Results | 2022 |
Ferric pyrophosphate citrate for parenteral administration of maintenance iron: structure, mechanism of action, clinical efficacy and safety.
Topics: Anemia; Anemia, Iron-Deficiency; Citrates; Dialysis Solutions; Diphosphates; Ferric Compounds; Hemoglobins; Humans; Inflammation; Iron; Renal Dialysis; Renal Insufficiency, Chronic; Treatment Outcome | 2022 |
Reactivity of Fe(III)-containing pyrophosphate salts with phenolics: complexation, oxidation, and surface interaction.
Topics: Diphosphates; Ferric Compounds; Food, Fortified; Iron; Phenols; Salts | 2023 |